Small cell lung cancer (SCLC) may increase the risk of pneumonia due to a weakened immune system or structural changes to the lungs. SCLC is one of the two main types of lung cancer. Pneumonia is ...

Small cell lung cancer (SCLC) is a fast-growing and highly malignant subtype of lung cancer. One of the biggest challenges doctors face is the cancer's resistance to platinum-based chemotherapy ...

Small cell lung cancer (SCLC) is a fast-growing cancer that develops in cells within the lung. A range of medical tests and procedures are available to help doctors diagnose SCLC and create an ...

ATLANTA, Ga. (Atlanta News First) - The president and CEO of the Southern Christian Leadership Conference (SCLC) will step ...

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for more than 80% of lung cancer cases. The treatment plan and goal of treatment depend on the stage of your ...

Opens in a new tab or window Treatment with the antibody drug-conjugate ifinatamab deruxtecan (I-DXd) showed promising activity in pretreated patients with extensive-stage small cell lung cancer ...

Patients with limited-stage small cell lung cancer saw improvements in progression-free survival and overall survival with Imfinzi versus placebo. Patients with limited-stage (cancer that is only on ...

Are you facing an unexpected expense? Whether it’s an urgent car repair, an unforeseen medical bill, or an essential home repair that can’t be delayed, a small personal loan might be just what ...

THE WEEK’S MOST POPULAR SONGS RANKED BY CHRISTIAN RADIO AIRPLAY AUDIENCE IMPRESSIONS, AS MEASURED BY MEDIABASE AND PROVIDED BY LUMINATE. STATIONS ARE ELECTRONICALLY MONITORED 24 HOURS A DAY, 7 ...

Bristol Myers Squibb’s (BMS) lung cancer monoclonal antibody BMS-986012 has nearly doubled overall survival (OS) in patients with extensive-stage small cell lung cancer (ES-SCLC) and brain ...

EGFR is a tyrosine kinase that participates in the regulation of cellular homeostasis. Following ligand binding, EGFR stimulates downstream cell signaling cascades that influence cell ...

Medically reviewed by Susan Russell, MDMedically reviewed by Susan Russell, MD Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for 80-85% of all cases.